Financing channel feed – Endpoints News

Financing channel feed

Casdin goes all-in on the SPAC game with $385M offering

5 years ago

Lumen Bioscience reels in $16M Series B to 'democratize' biologics

5 years ago

With biopharma IPOs surging, GoodRx guns for $750M raise

5 years ago

Cancer Research UK and NCI to kick off next rounds of Grand Challenges

5 years ago

Another biotech — Seattle-based Athira — files for an IPO, hoping to finally break through in Alzheimer's

5 years ago

Triumvira snags $55M Series A to guide TAC technology to the clinic

5 years ago

Clene Nanomedicine, researching the use of gold atoms to slow ALS progression, nets $42.5M Series D

5 years ago

Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms

5 years ago

Synthego adds $100M from RA, Wellington, 8VC in pursuit of 'virtualizing biology'

5 years ago

Riding on early cancer detection frenzy, Freenome scores $270M to push liquid biopsy tech beyond colorectal cancer

5 years ago

Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight

5 years ago

Kinnate gets $98M Series C to push precision oncology drugs to the clinic

5 years ago

A small VC group expands its hunt for inspired biotech founders in need of seed cash

5 years ago

Ovid gets quick raise off PhII seizure results. Can the results hold up against GW?

5 years ago

Connect Biopharma snags $115 million in Series C to develop arsenal of immune modulators

5 years ago

Driving to the $278M mark on raises, a legendary R&D expert sets his sights on another pivotal goal line

5 years ago

Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi

5 years ago

How big is the 2020 biotech IPO boom? More than $11 billion big among the year's four dozen entrants

5 years ago

Pharma giants back a leader in virtual clinical trials as Covid-19 blights sites

5 years ago

Kymera, raising $173M+, becomes the 48th biotech IPO of the year as 2020 surpasses 2019

5 years ago

Two more biotechs leverage upsized offerings in IPO boom as Harbour pitches a raise in Hong Kong

5 years ago

Alzheon returns, with a $47M NIH grant and one last shot at a pivotal PhIII Alzheimer’s success

5 years ago

Chinook raises $106M in private placement as it prepares to close merger with Aduro

5 years ago

Teamed up with Lyell, Juno/WuXi joint venture files IPO betting on China's CAR-T future

5 years ago

First page Previous page 92 93 949596 97 98 Next page Last page